CRL Expands Services in Asia

Clinical Reference Laboratory (CRL) has fully integrated its lab partner Phoenix Pharma Central Services in Singapore. The integration of Phoenix’s testing platforms into CRL’s Global LIMSystem enhances CRL’s support of clinical trials in Asia, adding efficiencies, increased quality, reduced costs and full global project oversight, as well as extensive knowledge of the Asian market and clinical trials.
 
Tim Sotos, chief executive officer of CRL, said, “We have a trusted relationship with Phoenix, having worked together for over a decade supporting a large number of clinical trials globally. “By incorporating Phoenix’s data into our centralized Global LIMSystem it allows for both sites and clinical teams to access their data throughout the world using CRL’s proprietary web-based ‘OASIS’ systems. This provides drug development companies with direct oversight on the status of their trial and allows them to evaluate drug safety on a real-time basis.”
 
Dr. Yan Lee, chief executive officer at Phoenix Pharma Central Services, said, “We have enjoyed a successful business relationship with CRL for a number of years and for the company to integrate us into their IT system shows a real commitment to both Phoenix and the industry.Together we are well positioned to provide support to pharmaceutical and biotechnological industries in the development of drugs and medical devices.”